These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29844327)

  • 21. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.
    Ansari MJ; Salama AD; Chitnis T; Smith RN; Yagita H; Akiba H; Yamazaki T; Azuma M; Iwai H; Khoury SJ; Auchincloss H; Sayegh MH
    J Exp Med; 2003 Jul; 198(1):63-9. PubMed ID: 12847137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of TNF-alpha and IFN-gamma mRNA expression in islets and spleen of NOD mice.
    Ventura-Oliveira D; Vilella CA; Zanin ME; Castro GM; Moreira Filho DC; Zollner RL
    Braz J Med Biol Res; 2002 Nov; 35(11):1347-55. PubMed ID: 12426635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.
    Li R; Lee J; Kim MS; Liu V; Moulik M; Li H; Yi Q; Xie A; Chen W; Yang L; Li Y; Tsai TH; Oka K; Chan L; Yechoor V
    Diabetes; 2015 Feb; 64(2):529-40. PubMed ID: 25332429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tryptophan metabolism promotes immune evasion in human pancreatic β cells.
    Rachdi L; Zhou Z; Berthault C; Lourenço C; Fouque A; Domet T; Armanet M; You S; Peakman M; Mallone R; Scharfmann R
    EBioMedicine; 2023 Sep; 95():104740. PubMed ID: 37536063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8+ T cell activity and biomarker during the evolution of Type 1 Diabetes.
    Rao C; Cater DT; Roy S; Xu J; Olivera AG; Evans-Molina C; Piganelli JD; Eizirik DL; Mirmira RG; Sims EK
    bioRxiv; 2024 Sep; ():. PubMed ID: 39345410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
    Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
    Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
    Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous retrovirus Gag antigen and its gene variants are unique autoantigens expressed in the pancreatic islets of non-obese diabetic mice.
    Dai YD; Dias P; Margosiak A; Marquardt K; Bashratyan R; Hu WY; Haskins K; Evans LH
    Immunol Lett; 2020 Jul; 223():62-70. PubMed ID: 32335144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
    Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
    J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.
    Mukherjee G; Chaparro RJ; Schloss J; Smith C; Bando CD; DiLorenzo TP
    Immunology; 2015 Apr; 144(4):631-40. PubMed ID: 25333865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia.
    Yantha J; Tsui H; Winer S; Song A; Wu P; Paltser G; Ellis J; Dosch HM
    Diabetes; 2010 Oct; 59(10):2588-96. PubMed ID: 20522597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
    Fife BT; Pauken KE; Eagar TN; Obu T; Wu J; Tang Q; Azuma M; Krummel MF; Bluestone JA
    Nat Immunol; 2009 Nov; 10(11):1185-92. PubMed ID: 19783989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
    Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
    Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.
    Schuster C; Brosi H; Stifter K; Boehm BO; Schirmbeck R
    PLoS One; 2013; 8(8):e71746. PubMed ID: 23977133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
    Ablamunits V; Elias D; Reshef T; Cohen IR
    J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoreactive T cells induce necrosis and not BCL-2-regulated or death receptor-mediated apoptosis or RIPK3-dependent necroptosis of transplanted islets in a mouse model of type 1 diabetes.
    Zhao Y; Scott NA; Fynch S; Elkerbout L; Wong WW; Mason KD; Strasser A; Huang DC; Kay TW; Thomas HE
    Diabetologia; 2015 Jan; 58(1):140-8. PubMed ID: 25301392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas.
    Rothe H; Ito Y; Kolb H
    J Mol Med (Berl); 2001 May; 79(4):190-7. PubMed ID: 11409710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
    Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
    Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.